DehydraTECH™ technology was invented in 2014 and has benefited from dedicated R&D advancements since.. DehydraTECH is now recognized as a global leader in enhancing the flavor, bouquet and gastro-intestinal delivery of edible cannabinoid consumer products. Although the technology has clear applicability within and beyond the cannabinoid sector, other industries are also recognizing benefits for other bioactive molecules, all of which are named within the patent portfolio (NSAIDs, nicotine, vitamins and more). Industry-leading research has supported this novel delivery method, including invitro, invivo, and human clinical testing. Multiple rounds of clinical study and observation have confirmed DehydraTECH to be a rapid and effective delivery technology.
None of this can happen without the talented and dedicated people who have supported DehydraTECH’s development and growth. Highly skilled experts, scientists and top management and advisors have all contributed to DehydraTECH’s development. Supporters have included industry leaders, research scientists, clinicians, analytical chemists, intellectual property experts, study volunteers, partnering company collaborators and, of course, the original inventors of the earliest iterations of DehydraTECH™ technology.
For those of you who have shared in our journey over the years, and for new participants as well, we thank you for being a part of our story.